Effect of JINSHIHOUTOU for patients with Pulmonary Mycobacterium avian complex infectio

Not Applicable

Recruiting

• Conditions: pulmonary Mycobacterium avian complex infection

• Registration Number: JPRN-UMIN000033590
• Lead Sponsor: Faculty of Medical Sciences University of Fukui

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-08-01
• Study Completion: 2021-01-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1.Rifampicin, ethambutol, clarithromycin, streptomycin, kanamycin, rifabutin, sitafloxacin, levofloxacin are administered 2.Treated for pulmonary tuberculosis 3.With hypokalemia 4.With heart failure 5.With drug hypersensitivity 6.Pregnant and lactating women 7.Patients who participated in other clinical trials within 4 months 8.In addition, patients who are judged inappropriate.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CAT score, body weight and NK cell activity on administration and 3 months later.

Secondary Outcome Measures

Name	Time	Method
Evaluation of exacerbation factors for exacerbation group and non-exacerbation group Depression score by SDS, STAI Chest CT findings Evaluation of exacerbation factors for exacerbation group and non-exacerbation group evaluation of safety